Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004369795 | SCV004914893 | uncertain significance | not specified | 2023-10-30 | criteria provided, single submitter | clinical testing | The c.2845A>G (p.S949G) alteration is located in exon 34 (coding exon 34) of the CACNA2D3 gene. This alteration results from a A to G substitution at nucleotide position 2845, causing the serine (S) at amino acid position 949 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003926973 | SCV004741304 | likely benign | CACNA2D3-related disorder | 2022-12-02 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |